Guardant Health
GH
#2480
Rank
A$9.34 B
Marketcap
$75.60
Share price
-5.93%
Change (1 day)
126.67%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2024 : -A$96.72 Million

According to Guardant Health 's latest financial reports the company has -A$96.72 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.23 B163.37%
2022-12-31$A$88.43 M-90.06%
2021-12-31$A$0.88 B-49.53%
2020-12-31$A$1.76 B45.56%
2019-12-31$A$1.21 B62.54%
2018-12-31$A$0.74 B88.51%
2017-12-31$A$0.39 B257.53%
2016-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$1.41 B-1,561.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.29 B-4,541.34%๐Ÿ‡บ๐Ÿ‡ธ USA